Lineage Cell Therapeutics In shares owned by Straight Path Wealth Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Straight Path Wealth Management
from 13F filings
Historical chart of Straight Path Wealth Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Straight Path Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Straight Path Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $24k | 16k | 1.48 |
| 2023-12-31 | $18k | 16k | 1.09 |
| 2023-09-30 | $19k | 16k | 1.18 |
| 2023-06-30 | $23k | 16k | 1.41 |
| 2023-03-31 | $24k | 16k | 1.50 |
| 2022-12-31 | $19k | 16k | 1.17 |
| 2022-09-30 | $18k | 16k | 1.11 |
| 2022-06-30 | $26k | 16k | 1.60 |
| 2022-03-31 | $25k | 16k | 1.54 |
| 2021-12-31 | $40k | 16k | 2.47 |
More positions owned by Straight Path Wealth Management
View all positions for Straight Path Wealth Management